Sumitomo Pharma Co.,Ltd. FY2026 Q3 Earnings Report | IR Tracker

Sumitomo Pharma Co.,Ltd. FY2026 Q3 Earnings Report | IR Tracker

Quick View

Metric	Current	Prior	YoY
Revenue	¥3477.5B	¥2931.8B	+18.6%
Operating Income	¥1097.7B	¥132.3B	+730.0%
Profit Before Tax	¥1015.4B	¥240.3B	+322.6%
Net Income	¥1076.8B	¥212.2B	+407.4%
ROE	37.3%	12.5%	-

Executive Summary

Performance Drivers

Segment Analysis

Key Metrics

Cash Flow Analysis

Earnings Quality

Guidance Update

Shareholder Returns

Catalysts

Industry Benchmark (Reference - Proprietary Data)

Risk Factors

Key Takeaways from Earnings

**